MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.advms.2020.01.002

Медицинская библиотека · Advances in medical sciences · 2020

Treatment and its side effects in ANCA-associated vasculitides - Study based on POLVAS registry data.

Biedroń Grzegorz, Włudarczyk Anna, Wawrzycka-Adamczyk Katarzyna, Wójcik Krzysztof, Sznajd Jan, Zdrojewski Zbigniew, Masiak Anna, Czuszyńska Zenobia, Majdan Maria, Jeleniewicz Radosław, Klinger Marian, Jakuszko Katarzyna, Rowaiye Olumide Olatubosun, Brzosko Marek, Brzosko Iwona, Dębska-Ślizień Alicja, Storoniak Hanna, Tłustochowicz Witold, Kur-Zalewska Joanna, Wisłowska Małgorzata, Madej Marta, Hawrot-Kawecka Anna, Głuszko Piotr, Kucharz Eugeniusz J, Musiał Jacek, Szczeklik Wojciech

СтатьяПеревод в очереди

Аннотация

PURPOSE: The aim of this study is to present the treatment modalities and associated side effects in a Polish nation-wide ANCA-associated vasculitides (AAV) patients' cohort.

MATERIALS AND

METHODS

Retrospective analysis of patients diagnosed with AAV between 1990 and 2016, included in the POLVAS registry was performed. Standard descriptive statistic methods were used with an emphasis on the treatment modalities.

RESULTS

There were 625 patients diagnosed with AAV included in this study: 417 cases of granulomatosis with polyangiitis (GPA; 66.7%), 106 cases of microscopic polyangiitis (MPA; 17.0%) and 102 cases of eosinophilic granulomatosis with polyangiitis (EGPA; 16.3%). The mean age at the date of diagnosis was 50.4 (±15.7) years and the median observational period amounted to 4.0 (2.0-8.0) years. Glucocorticosteroids (GCs) were the medicaments most frequently used for remission induction (593/622; 95.3%), followed by cyclophosphamide (487/622; 78.3%), rituximab (44/622; 7.1%), and methotrexate (39/622; 6.3%). GCs were also most frequently administered for maintenance therapy (499/592; 84.3%), followed by azathioprine (224/592; 37.8%), methotrexate (136/592; 23.0%) and mycophenolate mofetil (99/592; 16.7%). The median cumulative doses of cyclophosphamide and rituximab equalled 7.99 g (4.18-14.0) and 2000 mg (1500-2800), respectively. The most commonly observed adverse events included: infections - 214/551 cases (38.8%), which were associated with the time of observation (OR = 1.05; 95% CI 1.01-1.10), the use of GCs intravenous pulses (OR = 2.76; 95% CI 1.68-4.54) and need for haemodialysis (OR = 1.73; 95% CI 1.10-2.71).

CONCLUSIONS

Polish patients with AAV were predominantly treated according to appropriate guidelines. The most frequent adverse events were typical for usually administered immunosuppressive treatment.

Для цитирования: Biedroń Grzegorz, Włudarczyk Anna, Wawrzycka-Adamczyk Katarzyna, Wójcik Krzysztof, Sznajd Jan, Zdrojewski Zbigniew, Masiak Anna, Czuszyńska Zenobia, Majdan Maria, Jeleniewicz Radosław, Klinger Marian, Jakuszko Katarzyna, Rowaiye Olumide Olatubosun, Brzosko Marek, Brzosko Iwona, Dębska-Ślizień Alicja, Storoniak Hanna, Tłustochowicz Witold, Kur-Zalewska Joanna, Wisłowska Małgorzata, Madej Marta, Hawrot-Kawecka Anna, Głuszko Piotr, Kucharz Eugeniusz J, Musiał Jacek, Szczeklik Wojciech. Treatment and its side effects in ANCA-associated vasculitides - Study based on POLVAS registry data.. Advances in medical sciences. 2020. DOI: 10.1016/j.advms.2020.01.002.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.